Stay updated on Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Sign up to get notified when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.

Latest updates to the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page now displays the study record for the completed SONATA trial of lifitegrast for dry eye, including study details, participant criteria, locations, outcome measures, and results-related publications.SummaryDifference50%

- Check8 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0. The study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA notice about NIH’s terminology transition was added above the 403 error page. The site revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site release as v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content. This indicates the page is blocked due to permission restrictions, preventing viewing the study details.SummaryDifference0.5%

- Check50 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, blocking access to the NCT01636206 content. The UI presents a generic error page with standard navigation and footer instead of the study information.SummaryDifference17%

Stay in the know with updates to Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.